541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging

Benutzer: Gast

Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Spinner, Christoph D; Rashbaum, Bruce; Mcdonald, Cheryl; Mussini, Cristina; Luo, Donghan; Jezorwski, John; Brown, Kimberley; Wong, Eric Y
Titel:: 541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging
Zeitschriftentitel:: Open Forum Infectious Diseases
Jahr:: 2018
Band / Volume:: 5
Heft / Issue:: suppl_1
Seitenangaben Beitrag:: S201-S201
Volltext / DOI:: doi:10.1093/ofid/ofy210.550
Verlag / Institution:: Oxford University Press (OUP)
E-ISSN:: 2328-8957
Publikationsdatum:: 01.11.2018
BibTeX

Vorkommen: